Search
Depo-Provera
Indications:
1) contraception
2) endometriosis
Dosage:150 mg IM# every 3 months*
# Depo-subQ Provera-104 approved for SQ injection [5]
* abstain from intercourse for 7 days may be initiated at any time during the menstrual cycle no data on harm to fetus if initiated during pregnancy [4]
Injection: (suspension) 150 mg/mL (1 mL); 400 mg/mL (2.5 & 10 mL).
Adverse effects:
1) see medroxyprogesterone (Provera)
2) bone loss with Depo-Provera [1]
- only partially reversible [3]
3) increased risk of sexually transmitted disease with Depo Provera [2], including HIV [7]
4) increased risk of venous thromboembolism []
General
progestin-only contraceptive
References
- Journal Watch 21(21):173, 2001
Berenson et al Obstet Gynecol 98:576, 2001
- Journal Watch 24(19):149, 2004
Morrison CS et al, Hormonal conraceptive use, cervical
ectopy and the acquisition of cervical infection,
Sex Transm Dis 31:561, 2004
- Prescriber's Letter 12(1): 2005
Depo-Provera (Medroxyprogesterone Injectable Suspension) and
Bone Loss
Detail-Document#: 210111
(subscription needed) http://www.prescribersletter.com
- Journal Watch 25(8):66-67, 2005
Sneed R, Westhoff C, Morroni C, Tiezzi L.
A prospective study of immediate initiation of depo
medroxyprogesterone acetate contraceptive injection.
Contraception. 2005 Feb;71(2):99-103.
PMID: 15707558
- Prescriber's Letter 12(5): 2005
New Formulation: Depo-subQ Provera 104
Detail-Document#: 210513
(subscription needed) http://www.prescribersletter.com
- Mantha S et al
Assessing the risk of venous thromboembolic events in women
taking progestin-only contraception: a meta-analysis.
BMJ 2012;345:e4944
PMID: 22872710
http://www.bmj.com/content/345/bmj.e4944
- Ralph LJ et al
Hormonal contraceptive use and women's risk of HIV acquisition:
a meta-analysis of observational studies.
The Lancet Infectious Diseases. Online: Jan 2015
PMID: 25578825
http://www.thelancet.com/journals/lancetid/article/PIIS1473-3099%2814%2971052-7/abstract
Components
medroxyprogesterone actetate; acetoxymethylprogesterone (Provera, Cycrin, Amen)